Nordimet®: simply designed with patients in mind
Nordimet® is activated in 2 simple steps:
Press the needle shield against
the skin. First click confirms start of injection.
Second click confirms end of injection.
of patients successfully injected Nordimet®
in a ‘worst-case’ environment**
of patients described the injection process
Nordimet®: a range of indications and presentations
The dose should be reduced to the lowest possible
effective maintenance dose, once the desired therapeutic
result is achieved
The recommended initial dose is 7.5mg
once weekly, administered subcutaneously
Active rheumatoid arthritis (RA) in adult patients
Polyarthritic forms of severe, active juvenile idiopathic arthritis,
when the response to NSAIDs has been inadequate
Severe recalcitrant disabling psoriasis, which is not adequately
responsive to other forms of therapy such as phototherapy,
PUVA and retinoids
Severe psoriatic arthritis in adult patients
*Study included 42 RA patients and nurses/carers. Usability was based on a questionnaire with an adjusted 5-point Likert scale, with positive answers to closed questions defined as, for example, ‘Very useful’, ‘Useful’ or ‘Yes’.
**Dimmed light, TV or radio on, and phone ringing.